Results of systematic screening for serious gastrointestinal bleeding associated with NSAIDs in Rostock hospitals

Author(s): Pietzsch M, Theuer S, Haase G, Plath F, Keyser M, et al.


Objectives: Gastrointestinal bleeding and ulcers may lead to life-threatening complications. One of the causes is use of non-steroidal anti-inflammatory drugs (NSAIDs).

Methods: All hospital admissions in 1998 to the Departments of Internal Medicine, including the Intensive Care Unit and the Department of Surgery, in 2 hospitals in Rostock were prospectively screened for gastrointestinal bleeding. Whether the bleeding was due to an adverse drug reaction ADR or not was assessed using the rating scale of Begaud et al. [1985] for each drug taken. The risk profile and the drug history of all patients with gastrointestinal bleeding were registered.

Results: A total of 58 patients with gastrointestinal bleeding due to NSAIDs were documented. Risk factors for bleeding were cardiac diseases, hypertension, diabetes, age over 60 years, history of ulcer, a Helicobacter pylori infection, smoking and consumption of alcohol together with drugs known to have a risk of causing gastrointestinal bleeding and ulcers (antiplatelet drugs, anticoagulants, corticosteroids). About 70% of these patients had 3 or more risk factors, but only 20% had been receiving effective prophylaxis with a proton pump inhibitor.

Conclusion: Gastrointestinal problems resulting from the use of NSAIDs are clinically important. It is concluded, that individual risk profiles, as a criterion for the prophylactic use of effective protective drugs, would be helpful in patients management.

Similar Articles

Peptic ulcer in diabetes mellitus

Author(s): Masuda H, Inoue S, Arakawa H, Koizumi K, Kubo N

Gastric mucosal damage in experimental diabetes in rats: role of endogenous glutathione

Author(s): Goldin E, Ardite E, Elizalde JI, Odriozola A, Panés J, et al.

Increased susceptibility of diabetic rat gastric mucosa to food deprivation during cold stress

Author(s): Korolkiewicz R, Tashima K, Kubomi M, Kato S, Takeuchi K

Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects

Author(s): Perdichizzi G, Bottari M, Pallio S, Fera MT, Carbone M, et al.

4-Hydroxyisoleucine Experimental evidence of its insulinotropic and antidiabetic properties

Author(s): Broca C, Gross R, Petti P, Sauvaire Y, Manteghetti M, et al.

Antimutagenic and anticarcinogenic activity of Emblica officinalis

Author(s): Jose JK, Kuttan G, George J, Kuttan R

Protein measurement with the folin phenol reagent

Author(s): Lowry CH, Roosebrough NJ, Farr AL, Randall RJ

Combinatorial biosynthesis of novel antibiotics related to daptomycin

Author(s): Nguyen KT, Ritz D, Gu JQ, Alexander D, Chu M, et al.

Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intraduodenal fat

Author(s):  Brzozowski T, Konturek PC, Konturek SJ, Kwiecién S, Pajdo R, et al.

A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat

Author(s): Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, et al.

Alpha-glucosidase inhibitory activity of Syzygium cumini (Linn

Author(s): Shinde J, Taldone T, Barletta M, Kunaparaju N, Hu B, et al.

Influence of dietary quercetin on glutathione redox status in mice

Author(s): Meyers KJ, Rudolf JL, Mitchell AE

Effect of the flavonoid quercetin on inflammation and lipid peroxidation induced by Helicobacter pylori in gastric mucosa of guinea pig

Author(s): González-Segovia R, Quintanar JL, Salinas E, Ceballos-Salazar R, Aviles-Jiménez F, et al.